within Pharmacolibrary.Drugs.N_NervousSystem.N03A_Antiepileptics.N03AB03_AminoDiphenylhydantoinValericAci;

model AminoDiphenylhydantoinValericAci
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.9,
    Cl = 3.055555555555556e-07,
    adminDuration = 600,
    adminMass = 100 / 1000000,
    adminCount = 1,
    Vd = 0.00065,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0005,
    Tlag = 600);

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>AminoDiphenylhydantoinValericAcid</td></tr><tr><td>ATC code:</td><td>N03AB03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Amino(diphenylhydantoin) valeric acid is a structural analogue related to phenytoin, an antiepileptic drug, and has been historically researched for anticonvulsant properties. It is not approved for clinical use or marketed currently.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic (PK) models or human studies for amino(diphenylhydantoin) valeric acid have been identified in the scientific literature as of June 2024. Pharmacokinetic parameters below are theoretical estimates based on analogy to phenytoin.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N03AB03 folded in (Drugs.ATC removed)</li><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end AminoDiphenylhydantoinValericAci;
